Sanofi-Aventis Sa (GB:0A2V)
UK Market

Sanofi-Aventis Sa Stock Analysis & Ratings

GB:0A2V Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$54.6
Average Volume (3M)82.79K
Market Cap$135.05B
P/E RatioN/A
Next EarningsJul 28, 2022
Dividend Yield1.47 (2.8%)
1Y Price TargetN/A
Smart Score6
EPS (TTM)0.00



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Sanofi-Aventis Sa’s price range in the past 12 months?
Sanofi-Aventis Sa lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Sanofi-Aventis Sa’s market cap?
    Sanofi-Aventis Sa’s market cap is $135.05B.
      What is Sanofi-Aventis Sa’s price target?
      Currently, no data Available
      What do analysts say about Sanofi-Aventis Sa?
      Not enough analysts have published a price target to provide an average price target.
      When is Sanofi-Aventis Sa’s upcoming earnings report date?
      Sanofi-Aventis Sa’s upcoming earnings report date is Jul 28, 2022 which is in 69 days.
        How were Sanofi-Aventis Sa’s earnings last quarter?
        Sanofi-Aventis Sa released its earnings results on Apr 28, 2022. The company reported $1.015 earnings per share for the quarter, beating the consensus estimate of $0.961 by $0.054.
          Is Sanofi-Aventis Sa overvalued?
          According to Wall Street analysts Sanofi-Aventis Sa’s price is currently Overvalued.
            Does Sanofi-Aventis Sa pay dividends?
            Sanofi-Aventis Sa pays a Annually dividend of $1.47 which represents an annual dividend yield of 2.8%. Sanofi-Aventis Sa’s last Annually dividend payment was on Jun 08, 2022. Sanofi-Aventis Sa’s upcoming ex-dividend date is May 04, 2022
              What is Sanofi-Aventis Sa’s EPS estimate?
              Sanofi-Aventis Sa’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Sanofi-Aventis Sa have?
              Sanofi-Aventis Sa has 2,500,000,000 shares outstanding.
                What happened to Sanofi-Aventis Sa’s price movement after its last earnings report?
                Sanofi-Aventis Sa reported an EPS of $1.015 in its last earnings report, beating expectations of $0.961. Following the earnings report the stock price went down -0.918%.
                  Which hedge fund is a major shareholder of Sanofi-Aventis Sa?
                  Among the largest hedge funds holding Sanofi-Aventis Sa’s share is Dodge & Cox. It holds Sanofi-Aventis Sa’s shares valued at 5B.


                    Sanofi-Aventis Sa Stock Analysis

                    Smart Score
                    Price Target
                    No data currently available
                    The Sanofi-Aventis Sa stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Sanofi-Aventis Sa

                    Founded in 1973, Sanofi is a France-based leading global healthcare company, which provides therapeutic solutions worldwide. It operates through business units including Pharmaceuticals (comprised of General Medicines and Speciality Care), Consumer Healthcare, and Vaccines.

                    Similar Stocks
                    Price & Change
                    Merck & Company
                    Eli Lilly & Co
                    Bristol Myers

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis